IVERIC bio Stock Price

-0.25 (-4.08%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
IVERIC bio Inc ISEE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -4.08% 5.87 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.12 5.87 6.145 5.87 6.12
Bid Price Ask Price Spread News
5.75 6.02 0.27 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,139 339,745 $ 5.96 $ 2,026,347 987,805 3.3038 - 7.98
Last Trade Time Type Quantity Stock Price Currency
17:40:29 2 $ 5.87 USD

IVERIC bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 525.76M 89.57M 78.86M $ - $ - -1.39 -4.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

IVERIC bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ISEE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.506.525.876.17385,303-0.63-9.69%
1 Month6.596.635.606.21467,308-0.72-10.93%
3 Months5.906.784.96015.96613,512-0.03-0.51%
6 Months6.307.984.96016.31719,845-0.43-6.83%
1 Year3.437.983.30385.67800,3422.4471.14%
3 Years1.338.970.90594.94741,7434.54341.35%
5 Years1.338.970.90594.94741,7434.54341.35%

IVERIC bio Description

IVERIC bio Inc is a United States based gene therapy focused company developing treatments for patients with orphan inherited retinal diseases with unmet medical needs. Its gene therapy is a technology that seeks to correct a faulty gene by providing a healthy gene replacement, through a single treatment, resulting in the expression of a therapeutic protein that was otherwise not being produced.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.